AIC
DMK

Ameritas Investment Company’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Ameritas Investment Company’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-69
Closed -$11K – 1854
2018
Q4 		$11K Buy
+69
New +$13.2K ﹤0.01% 1030

Other funds holding DMK

First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

Ameritas Investment Company's DMK Position: Q1 2019 in Review

Ameritas Investment Company sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q1 2019, closing a stake of 69 shares — an estimated $11K sold.

Ameritas Investment Company first reported a position in DMK in Q4 2018 and held it in 1 quarter. The position peaked at $11K in Q4 2018. 57 funds tracked by Wall St. Rank hold DMK as of Q1 2019.

  • Ameritas Investment Company reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q1 2019 after selling out during the quarter.
  • Ameritas Investment Company sold 69 DMK Pharmaceuticals Corporation Common Stock shares in Q1 2019, an estimated $11K.
  • Ameritas Investment Company first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q4 2018 and held it in 1 quarter.
  • Ameritas Investment Company's DMK Pharmaceuticals Corporation Common Stock position peaked at $11K in Q4 2018.
  • 57 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q1 2019.

Based on Ameritas Investment Company's 13F filing for Q1 2019, filed 16 May 2019.